Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Martek Biosciences Corporation |
---|---|
Information provided by: | Martek Biosciences Corporation |
ClinicalTrials.gov Identifier: | NCT00278135 |
The purpose of this study is to investigate the effect of docosahexaenoic acid (DHA, 22:6n-3) in improving cognitive functions in subjects with age-related cognitive decline. DHA is a long chain omega-3 fatty acid (LC-PUFA) that plays an important role in neural and visual development and cardiovascular health.
Condition | Intervention |
---|---|
Age-Related Cognitive Decline Age-Related Memory Disorders |
Dietary Supplement: DHA (nutritional supplement) or placebo |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in the Elderly |
Estimated Enrollment: | 465 |
Study Start Date: | December 2005 |
Estimated Study Completion Date: | December 2008 |
Arms | Assigned Interventions |
---|---|
1: Active Comparator |
Dietary Supplement: DHA (nutritional supplement) or placebo
oral 900mg/day
|
2: Placebo Comparator |
Dietary Supplement: DHA (nutritional supplement) or placebo
oral 900mg/day
|
Ages Eligible for Study: | 55 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Arizona | |
Pivotal Research Center | |
Mesa, Arizona, United States, 85210 | |
United States, California | |
Pacific Research Network | |
San Diego, California, United States, 92103 | |
Pacific Research Network | |
Vista, California, United States, 92083 | |
United States, Colorado | |
Radiant Research Denver | |
Denver, Colorado, United States, 80212 | |
United States, Florida | |
Brain Matters Research | |
Delray Beach, Florida, United States, 33445 | |
Bradenton Neurology | |
Bradenton, Florida, United States, 34205 | |
Stedman Clinical Trials | |
Tampa, Florida, United States, 33613 | |
Meridien Research | |
St. Petersburg, Florida, United States, 33709 | |
United States, Illinois | |
Radiant Research Chicago | |
Chicago, Illinois, United States, 60610 | |
United States, Pennsylvania | |
Clinical Trial Center | |
Jenkintown, Pennsylvania, United States, 19046 | |
United States, Texas | |
Senior Adults Specialty Research | |
Austin, Texas, United States, 78757 | |
Radiant Research San Antonio | |
San Antonio, Texas, United States, 78229 | |
United States, Utah | |
Radiant Research Salt Lake City | |
Salt Lake City, Utah, United States, 84107 | |
United States, Vermont | |
Neurological Research Center, Inc. | |
Bennington, Vermont, United States, 05201 |
Study Director: | Karin Yurko-Mauro, PhD | Martek Biosciences Corporation |
Responsible Party: | Martek Biosciences ( Karin Yurko-Mauro ) |
Study ID Numbers: | 2005.1002 |
Study First Received: | January 13, 2006 |
Last Updated: | October 7, 2008 |
ClinicalTrials.gov Identifier: | NCT00278135 |
Health Authority: | United States: Institutional Review Board |
Cognition Memory Nutrition Omega-3 DHA |
Signs and Symptoms Neurologic Manifestations Neurobehavioral Manifestations Memory Disorders |
Nervous System Diseases |